Pharvaris N.V. - PHVS
Ownership (Schedule 13D / 13G) · latest 50 filings
· Back to all files
Visible: 0
| Filed | Form | Reporting person | Percent | Shares | SEC |
|---|---|---|---|---|---|
| Feb 17, 2026 | SCHEDULE 13G/A | Bain Capital Life Sciences Fund, L.P. | 2.5% | 1,640,817 | View |
| Feb 17, 2026 | SCHEDULE 13G/A | BCIP Life Sciences Associates, LP | 0.3% | 167,950 | View |
| Feb 17, 2026 | SCHEDULE 13G/A | Bain Capital Life Sciences Opportunities III, LP | 1.5% | 993,314 | View |
| Nov 14, 2025 | SCHEDULE 13G/A | Bain Capital Life Sciences Fund, L.P. | 3.0% | 1,867,629 | View |
| Nov 14, 2025 | SCHEDULE 13G/A | BCIP Life Sciences Associates, LP | 0.3% | 191,165 | View |
| Nov 14, 2025 | SCHEDULE 13G/A | Bain Capital Life Sciences Opportunities III, LP | 1.8% | 1,122,481 | View |
Percent = "% of class represented by amount beneficially owned" for this reporting person in the filed 13D/13G.
Shares = reported beneficial ownership amount for the same row (not portfolio shares from 13F).
Amendments (/A) can repeat the same holder over time, so rows should not be summed.
Extraction is best-effort from filing text and can be missing or noisy; verify exact figures via the SEC link in each row.